Nebraska gets $3.2M in settlement with drug company
By The Associated Press
Nebraska will receive almost $3.2 million as part of a $515 million settlement with a drug company accused of misconduct.
The settlement with Bristol-Myers Squibb and its former subsidiary, Apothecon Inc., was announced Tuesday. In addition to Nebraska, it includes the federal government, 42 other states and the District of Columbia.
Attorney General Jon Bruning says the settlement addresses allegations that the New York-based drug developer reported inflated prices for drugs to Medicaid and other federal health programs and misreported sale prices for an antidepressant, among other things.
The money reimburses excessive amounts paid by Medicaid programs as a result of the misconduct.

Facebook
del.icio.us
Fark It
Reddit





Post Your Comment
Standards and RulesYour posted comment will appear after it has been approved.
Frequently asked questions about story commenting.
kenny in cal wrote on July 17, 2008 10:41 pm:
Rose wrote on July 18, 2008 8:36 am:
Outside the Box wrote on July 18, 2008 8:42 am:
Making a photocopy of a lawsuit and replacing "Delaware" with "Nebraska" is hardly rocket science.
But it is a great way for Jon to get his name in the paper. "
do the math wrote on July 18, 2008 10:35 am:
Doug wrote on July 18, 2008 7:48 pm: